COMP <GO>
RGC vs DFTX // EV/EBITDA & P/E VALUATION
Regencell Bioscience Holdings Limited (NASDAQ) VS. Definium Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: RGC 1
— DFTX 3
■ METRIC PARITY
LAST: $6.71 (-2.19%) • MKT CAP: $3.40B
valuation
—
LAST: $36.33 (-4.29%) • MKT CAP: $5.10B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RGC VS. DFTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RGC | DFTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -32.20% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.10% | -3.84% | +3.74 | RGC | /fcf-yield <GO> |
| Operating Margin | — | -11.60% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -12.90% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 5.50% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 26.00 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 5/9 | -3.00 | DFTX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.1 | 55.4 | -11.30 | DFTX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 33.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.40B | $5.10B | -$1.70B | DFTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RGC REV | DFTX REV | RGC GROSS % | DFTX GROSS % | RGC FCF | DFTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | -$3.3M | -$131.6M |
| FY 2024 | $0 | $0 | — | — | -$4.0M | -$79.1M |
| FY 2023 | $0 | $0 | — | — | -$5.0M | -$64.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RGC // BETA —
DFTX // BETA 1.08